Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma

Explore clinical trials studying Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma trial results

Recruiting

PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy

NCT04745949

Conditions: Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma, +1 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma (1)
Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Lymphoma (1)
Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Lymphoma (1)

Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma

Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma trial results

PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy

Related conditions